1
|
Shafi H, Reddy DVS, Rashid R, Roy T, Kawoosa S, Bader GN, Jvus C, Abdal-Hay A, Beigh MA, Majeed S, Khan NA, Sheikh FA. Optimizing the fabrication of electrospun nanofibers of prochlorperazine for enhanced dissolution and permeation properties. BIOMATERIALS ADVANCES 2024; 158:213773. [PMID: 38277903 DOI: 10.1016/j.bioadv.2024.213773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 12/18/2023] [Accepted: 01/12/2024] [Indexed: 01/28/2024]
Abstract
Despite being an approved antiemetic for more than five decades, the clinical usefulness of prochlorperazine is limited by its low solubility and inconsistent absorption in the gastrointestinal tract, which presents challenges for nanotherapeutic interventions. Here, we report the preparation of a highly soluble and permeable nanofiber formulation of prochlorperazine using the Quality-by-Design approach. The final nanofiber formulation with drug entrapment of 88.02 ± 1.14 % was obtained at 20.0 kV, with a flow rate of 0.5 ml/h and tip-to-collector distance of 19.9 cm. Physio-mechanical properties, such as thickness (0.42 ± 0.02 mm), pH resistance (7.04 ± 0.08), folding endurance (54 ± 5), and tensile strength (0.244 ± 0.02 N.mm-2), were appropriate for packaging and application to oromucosal surfaces. The content uniformity (93.48-106.63 %) and weight variation (<1.8 mg) of the optimal nanofiber formulation were within the permissible limits prescribed for orodispersible films. Microscopical investigations confirm a randomly deposited and dense network of woven nanofibers with an average diameter of 363 ± 5.66 nm. The drug particles were embedded homogeneously on the fiber in the nanoform (4.27 ± 1.34 nm). The spectral analysis using TEM-EDS shows diffraction peaks of sulfur and chlorine, the elemental constituents of prochlorperazine. The drug was amorphized in the nanofiber formulation, as led by the decline of the crystallinity index from 87.25 % to 7.93 % due to electrostatic destabilization and flash evaporation of the solvent. The enthalpy of fusion values of the drug in the nanofiber mat decreased significantly to 23.6 J/g compared to its pristine form, which exhibits a value of 260.7 J/g. The nanofibers were biocompatible with oral mucosal cells, and there were no signs of mucosal irritation compared to 1 % sodium lauryl sulfate. The fiber mats rapidly disintegrated within <1 s and released ≈91.49 ± 2.1 % of the drug within 2 min, almost 2-fold compared to the commercial Stemetil MD® tablets. Similarly, the cumulative amount of the drug permeated across the unit area of the oromucosal membrane was remarkably high (31.28 ± 1.30 μg) compared to 10.17 ± 1.11 μg and 13.10 ± 1.79 μg from the cast film and drug suspension. Our results revealed these nanofiber formulations have the potential to be fast-dissolving oromucosal delivery systems, which can result in enhanced bioavailability with an early onset of action due to rapid disintegration, dissolution, and permeation.
Collapse
Affiliation(s)
- Hasham Shafi
- Nanostructured and Biomimetic Lab, Department of Nanotechnology, University of Kashmir, Srinagar 190006, Jammu and Kashmir, India; Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar 190006, Jammu and Kashmir, India; CSIR-Central Drug Research Institute, Jankipuram Extension, Lucknow, Uttar Pradesh 226031, India
| | - D V Siva Reddy
- CSIR-Central Drug Research Institute, Jankipuram Extension, Lucknow, Uttar Pradesh 226031, India
| | - Rumaisa Rashid
- Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar 190006, Jammu and Kashmir, India; CSIR-Central Drug Research Institute, Jankipuram Extension, Lucknow, Uttar Pradesh 226031, India
| | - Trisha Roy
- CSIR-Central Drug Research Institute, Jankipuram Extension, Lucknow, Uttar Pradesh 226031, India
| | - Shabnam Kawoosa
- Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar 190006, Jammu and Kashmir, India
| | - G N Bader
- Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar 190006, Jammu and Kashmir, India
| | - Chakradhar Jvus
- CSIR-Central Drug Research Institute, Jankipuram Extension, Lucknow, Uttar Pradesh 226031, India
| | - Abdalla Abdal-Hay
- Faculty of Industry and Energy Technology, Mechatronics Technology Program, New Cairo Technological University, New Cairo - Fifth Settlement, Cairo 11835, Egypt; Department of Engineering Materials and Mechanical Design, Faculty of Engineering, South Valley University, Qena 83523, Egypt; The University of Queensland, School of Dentistry, Oral Health Centre Herston, 288 Herston Road, Herston, QLD 4006, Australia; Cellular Signalling and Nanotherapeutics Laboratory, Department of Nanotechnology, University of KashmirHazratbal, Srinagar, Jammu and Kashmir, India
| | - Mushtaq A Beigh
- Cellular Signalling and Nanotherapeutics Laboratory, Department of Nanotechnology, University of KashmirHazratbal, Srinagar, Jammu and Kashmir, India
| | - Shafquat Majeed
- Laboratory for Multifunctional Nanomaterials, Department of Nanotechnology, University of Kashmir Hazratbal, Srinagar, Jammu and Kashmir 190006, India
| | - Nisar Ahmad Khan
- Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar 190006, Jammu and Kashmir, India.
| | - Faheem A Sheikh
- Nanostructured and Biomimetic Lab, Department of Nanotechnology, University of Kashmir, Srinagar 190006, Jammu and Kashmir, India.
| |
Collapse
|
2
|
Kean EA, Adeleke OA. Orally disintegrating drug carriers for paediatric pharmacotherapy. Eur J Pharm Sci 2023; 182:106377. [PMID: 36634740 DOI: 10.1016/j.ejps.2023.106377] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2022] [Revised: 01/06/2023] [Accepted: 01/07/2023] [Indexed: 01/11/2023]
Abstract
Non-compliance, dosing inaccuracy, choking risk, flavour, and instability, are some of the issues associated with paediatric, oral dosage forms - tablets, capsules, solutions, and suspensions. Orally disintegrating drug carriers, a dosage form with growing interest, are thought to overcome several of the challenges associated with these conventional formulations by rapidly disintegrating within the buccal cavity without the need for water. This review serves as an up-to-date report on the various types of orodispersible delivery systems, currently being developed or commercialized, by detailing their characteristics, manufacturing processes, and applications in the paediatric population. Mentioned are orodispersible tablets, films, wafers and lyophilisates, mini-tablets, capsules, granules, electrospun fibers and webs. Also highlighted are the choice of excipients, quality control requirements, and expected pharmacokinetics of orally disintegrating drug carriers concerning the paediatric population. Overall, orodispersible formulations, particularly tablets, films, and lyophilisates/wafers, have shown to be a valuable addition to medication administration in minors, thus the execution of more targeted research and development activities is expected to lead to enhanced paediatric care and outcomes.
Collapse
Affiliation(s)
- Emma A Kean
- College of Pharmacy, Faculty of Health, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada
| | - Oluwatoyin A Adeleke
- College of Pharmacy, Faculty of Health, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.
| |
Collapse
|
3
|
Chen FC, Liu WJ, Zhu WF, Yang LY, Zhang JW, Feng Y, Ming LS, Li Z. Surface Modifiers on Composite Particles for Direct Compaction. Pharmaceutics 2022; 14:pharmaceutics14102217. [PMID: 36297653 PMCID: PMC9612340 DOI: 10.3390/pharmaceutics14102217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Revised: 10/13/2022] [Accepted: 10/13/2022] [Indexed: 11/16/2022] Open
Abstract
Direct compaction (DC) is considered to be the most effective method of tablet production. However, only a small number of the active pharmaceutical ingredients (APIs) can be successfully manufactured into tablets using DC since most APIs lack adequate functional properties to meet DC requirements. The use of suitable modifiers and appropriate co-processing technologies can provide a promising approach for the preparation of composite particles with high functional properties. The purpose of this review is to provide an overview and classification of different modifiers and their multiple combinations that may improve API tableting properties or prepare composite excipients with appropriate co-processed technology, as well as discuss the corresponding modification mechanism. Moreover, it provides solutions for selecting appropriate modifiers and co-processing technologies to prepare composite particles with improved properties.
Collapse
Affiliation(s)
- Fu-Cai Chen
- Key Laboratory of Preparation of Modern TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China
| | - Wen-Jun Liu
- Jiangzhong Pharmaceutical Co., Ltd., Nanchang 330049, China
| | - Wei-Feng Zhu
- Key Laboratory of Preparation of Modern TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China
| | - Ling-Yu Yang
- Jiangzhong Pharmaceutical Co., Ltd., Nanchang 330049, China
| | - Ji-Wen Zhang
- Key Laboratory of Preparation of Modern TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Yi Feng
- Key Laboratory of Preparation of Modern TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China
- Engineering Research Center of Modern Preparation Technology of TCM of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
| | - Liang-Shan Ming
- Key Laboratory of Preparation of Modern TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China
- Correspondence: (L.-S.M.); (Z.L.); Tel.: +86-791-8711-9027 (L.-S.M. & Z.L.)
| | - Zhe Li
- Key Laboratory of Preparation of Modern TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China
- Correspondence: (L.-S.M.); (Z.L.); Tel.: +86-791-8711-9027 (L.-S.M. & Z.L.)
| |
Collapse
|
4
|
Zhao P, Chen W, Feng Z, Liu Y, Liu P, Xie Y, Yu DG. Electrospun Nanofibers for Periodontal Treatment: A Recent Progress. Int J Nanomedicine 2022; 17:4137-4162. [PMID: 36118177 PMCID: PMC9480606 DOI: 10.2147/ijn.s370340] [Citation(s) in RCA: 42] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2022] [Accepted: 08/31/2022] [Indexed: 12/11/2022] Open
Abstract
Periodontitis is a major threat to oral health, prompting scientists to continuously study new treatment techniques. The nanofibrous membrane prepared via electrospinning has a large specific surface area and high porosity. On the one hand, electrospun nanofibers can improve the absorption capacity of proteins and promote the expression of specific genes. On the other hand, they can improve cell adhesion properties and prevent fibroblasts from passing through the barrier membrane. Therefore, electrospinning has unique advantages in periodontal treatment. At present, many oral nanofibrous membranes with antibacterial, anti-inflammatory, and tissue regeneration properties have been prepared for periodontal treatment. First, this paper introduces the electrospinning process. Then, the commonly used polymers of electrospun nanofibrous membranes for treating periodontitis are summarized. Finally, different types of nanofibrous membranes prepared via electrospinning for periodontal treatment are presented, and the future evolution of electrospinning to treat periodontitis is described.
Collapse
Affiliation(s)
- Ping Zhao
- School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai, People's Republic of China
| | - Wei Chen
- School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai, People's Republic of China
| | - Zhangbin Feng
- School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai, People's Republic of China
| | - Yukang Liu
- School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai, People's Republic of China
| | - Ping Liu
- The Base of Achievement Transformation, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai, 200433, People's Republic of China.,Institute of Orthopaedic Basic and Clinical Transformation, University of Shanghai for Science and Technology, Shanghai, 200093, People's Republic of China
| | - Yufeng Xie
- Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, People's Republic of China
| | - Deng-Guang Yu
- School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai, People's Republic of China.,Shanghai Engineering Technology Research Center for High-Performance Medical Device Materials, Shanghai, 200093, People's Republic of China
| |
Collapse
|
5
|
Electrospun Structural Hybrids of Acyclovir-Polyacrylonitrile at Acyclovir for Modifying Drug Release. Polymers (Basel) 2021; 13:polym13244286. [PMID: 34960834 PMCID: PMC8708694 DOI: 10.3390/polym13244286] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2021] [Revised: 12/04/2021] [Accepted: 12/05/2021] [Indexed: 01/19/2023] Open
Abstract
In traditional pharmaceutics, drug–crystalline nanoparticles and drug–polymer composites are frequently explored for their ability to modify drug release profiles. In this study, a novel sort of hybrid with a coating of acyclovir crystalline nanoparticles on acyclovir-polyacrylonitrile composites was fabricated using modified, coaxial electrospinning processes. The developed acyclovir-polyacrylonitrile at the acyclovir nanohybrids was loaded with various amounts of acyclovir, which could be realized simply by adjusting the sheath fluid flow rates. Compared with the electrospun composite nanofibers from a single-fluid blending process, the nanohybrids showed advantages of modifying the acyclovir release profiles in the following aspects: (1) the initial release amount was more accurately and intentionally controlled; (2) the later sustained release was nearer to a zero-order kinetic process; and (3) the release amounts at different stages could be easily allocated by the sheath fluid flow rate. X-ray diffraction results verified that the acyclovir nanoparticles were in a crystalline state, and Fourier-transform infrared spectra verified that the drug acyclovir and the polymer polyacrylonitrile had a good compatibility. The protocols reported here could pave the way for developing new types of functional nanostructures.
Collapse
|
6
|
Orodispersible Membranes from a Modified Coaxial Electrospinning for Fast Dissolution of Diclofenac Sodium. MEMBRANES 2021; 11:membranes11110802. [PMID: 34832031 PMCID: PMC8622798 DOI: 10.3390/membranes11110802] [Citation(s) in RCA: 38] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/28/2021] [Revised: 10/19/2021] [Accepted: 10/20/2021] [Indexed: 01/15/2023]
Abstract
The dissolution of poorly water-soluble drugs has been a longstanding and important issue in pharmaceutics during the past several decades. Nanotechnologies and their products have been broadly investigated for providing novel strategies for resolving this problem. In the present study, a new orodispersible membrane (OM) comprising electrospun nanofibers is developed for the fast dissolution of diclofenac sodium (DS). A modified coaxial electrospinning was implemented for the preparation of membranes, during which an unspinnable solution of sucralose was explored as the sheath working fluid for smoothing the working processes and also adjusting the taste of membranes. SEM and TEM images demonstrated that the OMs were composed of linear nanofibers with core-sheath inner structures. XRD and ATR-FTIR results suggested that DS presented in the OMs in an amorphous state due to the fine compatibility between DS and PVP. In vitro dissolution measurements and simulated artificial tongue experiments verified that the OMs were able to release the loaded DS in a pulsatile manner. The present protocols pave the way for the fast dissolution and fast action of a series of poorly water-soluble active ingredients that are suitable for oral administration.
Collapse
|
7
|
Phadke A, Amin P. A Recent Update on Drug Delivery Systems for Pain Management. J Pain Palliat Care Pharmacother 2021; 35:175-214. [PMID: 34157247 DOI: 10.1080/15360288.2021.1925386] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Pain remains a global health challenge affecting approximately 1.5 billion people worldwide. Pain has been an implicit variable in the equation of human life for many centuries considering different types and the magnitude of pain. Therefore, developing an efficacious drug delivery system for pain management remains an open challenge for researchers in the field of medicine. Lack of therapeutic efficacy still persists, despite high throughput studies in the field of pain management. Research scientists have been exploiting different alternatives to curb the adverse side effects of pain medications or attempting a more substantial approach to minimize the prevalence of pain. Various drug delivery systems have been developed such as nanoparticles, microparticles to curb adverse side effects of pain medications or minimize the prevalence of pain. This literature review firstly provides a brief introduction of pain as a sensation and its pharmacological interventions. Second, it highlights the most recent studies in the pharmaceutical field for pain management and serves as a strong base for future developments. Herein, we have classified drug delivery systems based on their sizes such as nano, micro, and macro systems, and for each of the reviewed systems, design, formulation strategies, and drug release performance has been discussed.
Collapse
|
8
|
|